Made by doctors
Our team has a variety of backgrounds in healthcare and technology.
The company, founded in 2018, has developed one of the world’s first ECG devices that can measure heart signals anywhere and anytime.
Behind MedBeat is a team with a broad background from healthcare and the technology industry who understand the importance of making a product that is easy to use.
One of the challenges in medicine today is cardiac arrhythmias. The most common is atrial fibrillation that exists in around 2% of the world’s population. The biggest problem with atrial fibrillation is not the irregular heartbeat, but the blood clots that occur. Studies have shown that about 30% of all strokes are associated with atrial fibrillation.
MedBeat’s device can detect several different arrhythmias, including atrial fibrillation. It can be used anywhere – e.g. at home, at work or at training. The device is used to diagnose known symptoms which could prevent future disease such as sudden cardiac death and stroke.